🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nicole Grunenberg

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

ORCID: 0000-0003-2565-3879

Also affiliated with Fred Hutch Cancer Center

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines”.

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

PLoS Medicine(2020)10.1371/journal.pmed.1003038

N/A

1.2DataRank · unranked

48 citations

Zoe Moodie, Kristen W. Cohen, Nicole Grunenberg, Linda‐Gail Bekker, Mary Allen +26 more

Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac260

N/A

1.1DataRank · unranked

50 citations

One Dintwe, Sheetal Sawant, Doug Grove, Yunda Huang, Holly Janes +43 more

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00263-1

N/A

0.750DataRank · unranked

24 citations

Nadine Rouphael, Stephen R. Walsh, Aiying Chen, Nicole Grunenberg, Mary Allen +95 more

Safety and immunogenicity of a polyvalent DNA–protein HIV vaccine with matched Env immunogens delivered as a prime–boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial

The Lancet HIV(2024)10.1016/s2352-3018(24)00036-5

N/A

0.530DataRank · unranked

10 citations

Shuying S. Li, Nicole Grunenberg, Edgar T. Overton, Samuel T. Robinson, Hua Zheng +20 more

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial

PLoS Medicine(2024)10.1371/journal.pmed.1004360

N/A

0.439DataRank · unranked

9 citations

Erica Andersen‐Nissen, Nicole Grunenberg, One Dintwe, Faatima Laher Omar, Jia Jin Kee +29 more

Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad434

N/A

0.395DataRank · unranked

7 citations

Fatima Laher, One Dintwe, Monde Muyoyeta, Allan C. deCamp, Zonglin He +27 more

An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals

medRxiv(2024)10.1101/2024.03.15.24304305

N/A

0.375DataRank · unranked

7 citations

Wilton B. Williams, Stephen R. Walsh, Derek W. Cain, Matthew Clark, Ryan Tuck +38 more

A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials

Emerging Microbes & Infections(2025)10.1080/22221751.2025.2485317

N/A

0.260DataRank · unranked

4 citations

Shuying Sue Li, Elena Giorgi, LaTonya D. Williams, One Dintwe, Lindsay N. Carpp +34 more

Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa

AIDS and Behavior(2023)10.1007/s10461-023-04025-z

N/A

0.208DataRank · unranked

3 citations

Fatima Laher, Athmanundh Dilraj, Philip Smith, Glenda Gray, Doug Grove +16 more

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1–2 randomized double-blind placebo-controlled trial

PLOS Global Public Health(2024)10.1371/journal.pgph.0003319

N/A

0.108DataRank · unranked

1 citations

Fatima Laher, Linda‐Gail Bekker, Kelly E. Seaton, Mary Allen, Stephen De Rosa +27 more

Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses

Viruses(2024)10.3390/v16091365

N/A

0DataRank · unranked

2 citations

S. Munir Alam, Erica Andersen‐Nissen, Lindsay N. Carpp, One Dintwe, Britta Flach +12 more

HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens

Scientific Reports(2020)10.1038/s41598-020-57491-z

N/A

0DataRank · unranked

24 citations

Fatima Laher, Zoe Moodie, Arthur S. McMillan, Rachel L. Spreng, Peter B. Gilbert +15 more

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk

PLoS Pathogens(2021)10.1371/journal.ppat.1009363

N/A

0DataRank · unranked

30 citations

Andrew Fioré-Gartland, Lamar M. Fleming, Lindsay N. Carpp, Anneta Naidoo, Michael S. Harper +13 more

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

PLoS Medicine(2020)10.1371/journal.pmed.1003117

N/A

0DataRank · unranked

14 citations

Stephen R. Walsh, Fatima Laher, Lucas Maganga, Michael E. Herce, Sarita Naidoo +28 more

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans

npj Vaccines(2021)10.1038/s41541-021-00305-8

N/A

0DataRank · unranked

15 citations

Aaron Deal, Xue Han, Shuying S. Li, Ashley Clayton, Jack Heptinstall +25 more